ArticleCancer immunology, immunotherapy : CII2011

Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine.

Mengyong Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.